Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer

• Zhenbin Chen,

  Affiliation Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Jinong Feng,

  Affiliation Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Carolyn H. Buzin,

  Affiliations Department of Molecular Diagnosis, City of Hope National Medical Center, Duarte, California, United States of America, MEDomics, LLC, Azusa, California, United States of America

  ⨯
• Qiang Liu,

  Affiliation Department of Molecular Diagnosis, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Lawrence Weiss,

  Affiliation Department of Anatomic Pathology, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Kemp Kernstine,

  Affiliation Division of Surgery, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• George Somlo,

  Affiliation Department of Medical Oncology, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Steve S. Sommer

  * E-mail: ssommer@medomics.com

  Affiliations Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California, United States of America, Department of Molecular Diagnosis, City of Hope National Medical Center, Duarte, California, United States of America, MEDomics, LLC, Azusa, California, United States of America

  ⨯